| Kroetz, Deanna L |
Ohio State University
United States |
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity |
5R01CA261068-06 |
Rachel Altshuler, Ph.D. |
| Afshar-Kharghan, Vahid |
University Of Tx Md Anderson Can Ctr
United States |
Novel Biomarkers Predicting Blood Clots in Ovarian Cancer |
5R01CA275762-03 |
Rachel Altshuler, Ph.D. |
| Khasabov, Sergey G |
University Of Minnesota
United States |
Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling |
5R01CA263777-05 |
Rachel Altshuler, Ph.D. |
| Mao, Jun J |
Sloan-Kettering Inst Can Research
United States |
Enhanced Pain Coping in Cancer (EPIC) |
5R01CA285746-02 |
Rachel Altshuler, Ph.D. |
| Shiozawa, Yusuke |
Wake Forest University Health Sciences
United States |
Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy |
5R21CA297068-02 |
Rachel Altshuler, Ph.D. |
| Ross, Stephen |
New York University School Of Medicine
United States |
Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress |
5R01CA268521-04 |
Rachel Altshuler, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Targeting neuronal transport to ameliorate vincristine neurotoxicity |
5R01CA272254-03 |
Rachel Altshuler, Ph.D. |
| Yang, Qing |
University Of Texas Med Br Galveston
United States |
The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy |
5R01CA273001-02 |
Rachel Altshuler, Ph.D. |
| Spiegel, Brennan |
Cedars-Sinai Medical Center
United States |
Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
5R01CA252211-05 |
Rachel Altshuler, Ph.D. |
| Salvemini, Daniela |
Saint Louis University
United States |
Fingolimod and Ozanimod for the treatment and prevention of chemobrain |
5R01CA261979-04 |
Rachel Altshuler, Ph.D. |
